Combination Niraparib and Dostarlimab Therapy for Recurrent or Persistent Uterine Serous Carcinoma
Clinical trial NCT05870761 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05870761
- Sponsor
- Casey Cosgrove
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-17
- Primary completion
- 2025-09-19
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.